TWP
GILD icon

Tempus Wealth Planning’s Gilead Sciences GILD Stock Holding History

Tempus Wealth Planning’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$267K Buy
2,116
+216
+11% +$28.5K 0.05% 241
2026
Q1 		$265K Buy
1,900
+66
+4% +$9.24K 0.06% 233
2025
Q4 		$225K Buy
+1,834
New +$223K 0.05% 257
2020
Q4 		– Sell
-1,239
Closed -$78K – 84
2020
Q3 		$78K Buy
+1,239
New +$85.9K 0.11% 70

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tempus Wealth Planning's GILD Position: Q2 2026 in Review

Tempus Wealth Planning increased its Gilead Sciences (GILD) stake by 11% in Q2 2026, buying an estimated $28.5K and bringing the position to 2,116 shares worth $267K. The position accounts for 0.05% of the portfolio, ranked #241.

Tempus Wealth Planning first reported a position in GILD in Q3 2020 and has held it in 4 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Tempus Wealth Planning held 2,116 shares of Gilead Sciences worth $267K as of Q2 2026.
  • Tempus Wealth Planning bought 216 Gilead Sciences shares in Q2 2026, an estimated $28.5K.
  • Gilead Sciences made up 0.05% of Tempus Wealth Planning's portfolio in Q2 2026, its #241 holding.
  • Tempus Wealth Planning first reported a position in Gilead Sciences in Q3 2020 and has held it in 4 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Tempus Wealth Planning's 13F filing for Q2 2026, filed 22 Jul 2026.